CN107929451A - One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof - Google Patents
One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof Download PDFInfo
- Publication number
- CN107929451A CN107929451A CN201711341561.8A CN201711341561A CN107929451A CN 107929451 A CN107929451 A CN 107929451A CN 201711341561 A CN201711341561 A CN 201711341561A CN 107929451 A CN107929451 A CN 107929451A
- Authority
- CN
- China
- Prior art keywords
- grams
- stagnation
- depression
- liver
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/754—Evodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses one kind to treat stagnation of QI due to depression of the liver particle and preparation method thereof, and stagnation of QI due to depression of the liver particle includes green peel, dried orange peel, Chinese herbaceous peony, moutan bark, cape jasmine (stir-fry), rhizoma alismatis, the rhizoma bolbostemmae.The stagnation of QI due to depression of the liver particle of the present invention, using common Chinese medicine material, scientific formulation, using the formulation of granule, dispersion degree is big for raw material, absorbs soon, and medicine arrival disease institute is rapid, significantly improves curative effect, treats both principal and secondary aspect of disease, clinical practice is safe.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines, more particularly to a kind of stagnation of QI due to depression of the liver particle and preparation method thereof.
Background technology
Liver depression and Qi stagnation refers to the catharsis dysfunction due to liver, and catharsis is too late and causes stagnant the showed feelings will suppression of the mechanism of qi stasis of blood
Strongly fragrant, chest side of body or few distention and fullness in the abdomen alter pain, depressed emotion or irritability, sighing frequently, or see foreign body in pharynx sense, or under neck goiter and tumor, or the side of body
Lump;The visible swollen breasts of women, irregular menstruation, dysmenorrhoea, thin white fur of tongue, the syndrome of veins string.Also known as hepatic depression combined symptoms, abbreviation liver
Strongly fragrant disease.Assertive evidence is more because feelings will is unsuccessful, or is subject to direct stimulation suddenly, or because disease and evil is invaded and harassed, checks liver arteries and veins, causes irritability to lose in thin
Let out, bar is up to caused.
1. caused by hepatic stagnation qi stagnation is had a stomachache
(1)Cause of disease irritability is lost in free flow of qi, horizontal criminal's taste, and causes liver-stomach disharmony or incoordination between the liver and the spleen, and qi and blood blocks and causes stomachache.
(2)Gastral cavity pain is showed, even and two coerce, and attack support and walk to alter, are often aggravated, sighing frequently, do not feel like eating because feelings will is unsuccessful,
Sleep poor thin white fur of tongue, veins string.
(3)Rules for the treatment of soothing liver and harmonizing stomach, regulating qi-flowing for relieving pain.
(4)Main side's bupleurum powder for relieving liver-qi plus-minus.
2. caused by hepatic stagnation qi stagnation feeling of fullness
(1)Cause of disease feelings will is become estranged, the well-behaved unrest of mechanism of qi, the too then impairment of the spleen of being worried, and the angry too then impariment of the liver, liver and spleen depression and stagnation of QI, influences
Gastral cavilty and drop, disturbance in ascending and descending, triggers feeling of fullness.
(2)Performance gastral cavity abdomen ruffian plug is swollen it is vexed do not relax, even and two sides of body, belch then relaxes, dysphoria, when heave a deep sigh, often because of feelings will
Factor and aggravate, tongue is thin white, veins string.
(3)Rules for the treatment of soothing liver-qi stagnation, qi-regulating disappear spleen.
(4)Main side's bupleurum powder for relieving liver-qi or banxia houpu decoction plus-minus.
3. caused by hepatic stagnation qi stagnation hiccup
(1)Cause of disease stagnation of liver qi, loses and is reached in tune, thus irritability multiply it is inverse in impulsion on stomach, stomach Qi every into hiccup.
(2)Show hiccup repeatedly, fullness in chest and hypochondrium, or borborygmus fart, or breathing are unfavorable, or nauseous belch, the vexed deficiency of food of gastral cavity, tongue
Greasy and thin fur, string and slide.
(3)Rules for the treatment of regulating qi-flowing for eliminating phlegm, drop check is oh.
(4)Main side's XUAN FU DAI ZHE decoction plus-minus.
4. caused by hepatic stagnation qi stagnation abdominal pain
(1)Cause of disease depression is angry, and irritability is lost in free flow of qi, functional activity of QI being not smooth, the stagnation of the circulation of vital energy and pain;Or melancholy,anxiety and spleen, or liver depression gram spleen,
Liver-stomach disharmony, disorder of qi, abdomen gas loses sends out abdominal pain in logical drop, or the stagnation of the circulation of vital energy is with the passing of time, hematogenous blockage, and qi depression to blood stasis is in abdomen, arteries and veins
Network is obstructed and causes abdominal pain.
(2)Show abdominal pain, turgor do not relax, and migratory pain, attacks support and walk to alter, and often triggers few abdomen, when it is poly- when dissipate, obtain belch
Then relax, often aggravated, thin white fur of tongue, veins string because feelings will is unsuccessful.
(3)Rules for the treatment of soothing liver and harmonizing stomach, regulating qi-flowing for relieving pain.
(4)Main side's bupleurum powder for relieving liver-qi plus-minus.
5. caused by hepatic stagnation qi stagnation constipation
(1)Cause of disease feelings will is become estranged, and stagnation of liver qi, loses and reached in tune, causes to conduct mistake department so as to cause constipation.
(2)Performance dry and hard excrement, be intended to just not go out, turgor in abdomen, and with seeing that painful chest and hypochondrium is vexed, belch hiccup, loses the appetite, borborygmus
Fart, not smooth after an action of the bowels, thin white fur of tongue, or thin Huang, veins string.
(3)The rules for the treatment of are pleasant to lead stagnant, the inverse defaecation of drop.
(4)Main side's Liumotang plus-minus.
6. caused by hepatic stagnation qi stagnation hypochondriac pain
(1)Cause of disease depression is angry, emotional discomfort, and irritability is lost and closed in free flow of qi, functional activity of QI being not smooth, vapour lock network, sends out as hypochondriac pain.
(2)The distending pain in hypochondrium is showed, walks to alter, migratory pain, often increases and decreases because feelings offer congratulations anger, gastral cavity ruffian uncomfortable in chest, diet is reduced,
Gas frequency is made, and sighing frequently, tongue is thin, veins string.
(3)Therapy dispersing stagnated hepatoqi relieves pain.
(4)Main side's bupleurum powder for relieving liver-qi plus-minus.
The content of the invention
In order to solve problem of the prior art, an embodiment of the present invention provides a kind of stagnation of QI due to depression of the liver particle and its preparation side
Method.The technical solution is as follows:
On the one hand, a kind of stagnation of QI due to depression of the liver particle, including green peel, dried orange peel, Chinese herbaceous peony, moutan bark, cape jasmine (stir-fry), rhizoma alismatis, the rhizoma bolbostemmae.
Further, stagnation of QI due to depression of the liver particle includes 5-12 grams of evodia rutaecarpa, 5-12 grams of ginseng, 12-20 grams of ginger, jujube 4-8
Gram.
Further, stagnation of QI due to depression of the liver particle includes 6 grams of green peel, 6 grams of dried orange peel, 6 grams of Chinese herbaceous peony, 5 grams of moutan bark, cape jasmine (stir-fry) 5
Gram, 5 grams of rhizoma alismatis, 6 grams of the rhizoma bolbostemmae.
On the other hand, the preparation method of stagnation of QI due to depression of the liver particle, comprises the following steps:
(1) green peel, dried orange peel, Chinese herbaceous peony are taken, moutan bark, cape jasmine (stir-fry), rhizoma alismatis, the rhizoma bolbostemmae, it is small that 6 times of water of dosing material total amount decoct 2
When after filter, take the dregs of a decoction after filtering add again 8 times of water decoct 2 it is small when, filtering, discards the dregs of a decoction, merges filtrate twice;
(2) filtrate after merging is concentrated, is subsequently cooled to room temperature, add ethanol, it is stirring while adding, when placement 12 is small, mistake
Filter, takes filtrate recycling ethanol to be concentrated to give thick paste to no alcohol taste;
(3) auxiliary material and thick paste are taken, is pelletized after mixing, by whole grain after particle drying to obtain the final product.
Further, relative density is 1.10-1.30 when the filtrate after merging being concentrated into 60-70 DEG C in step (2).
Further, the relative density that thick paste is concentrated to give in step (2) at 70-80 DEG C is 1.25-1.30.
Further, auxiliary material includes mannitol and microcrystalline cellulose in step (3).
Further, thick paste by quality ratio in step (3):Mannitol:Microcrystalline cellulose=1:0.3:0.15.
Further, drying temperature is 50-60 DEG C in step (3).
Further, ethanol is added in step (2) to alcohol content in 50-60%.
The beneficial effect that technical solution provided in an embodiment of the present invention is brought is:The stagnation of QI due to depression of the liver particle of the present invention, uses
Common Chinese medicine material is raw material, and scientific formulation, using the formulation of granule, dispersion degree is big, absorb it is fast, medicine reach disease institute it is rapid,
Curative effect is significantly improved, is treated both principal and secondary aspect of disease, clinical practice safety.
Embodiment
To make the object, technical solutions and advantages of the present invention clearer, embodiment of the present invention will be made into one below
It is described in detail on step ground.
Embodiment 1
(1) 6 grams of green peel, 6 grams of dried orange peel, 6 grams of Chinese herbaceous peony are taken, 5 grams of moutan bark, 5 grams of cape jasmine (stir-fry), 5 grams of rhizoma alismatis, 6 grams of the rhizoma bolbostemmae, add
6 times of water of medicinal material total amount decoct 2 it is small when after filter, take the dregs of a decoction after filtering add again 8 times of water decoct 2 it is small when, filtering, discards medicine
Slag, merges filtrate twice;
(2) relative density is 1.10-1.30 when the filtrate after merging being concentrated into 60-70 DEG C, is subsequently cooled to room temperature, adds second
Alcohol, it is stirring while adding to alcohol content in 50-60%, place 12 it is small when, filtering, takes filtrate recycling ethanol to be concentrated to give to no alcohol taste
To 70-80 DEG C relative density be 1.25-1.30 thick paste;
(3) mannitol, microcrystalline cellulose and thick paste (thick paste are taken:Mannitol:Microcrystalline cellulose=1:0.3:0.15), it is uniformly mixed
After pelletize, whole grain after 50-60 DEG C of dry particle to obtain the final product.
Embodiment 2
(1) take including 10 grams of green peel, 6 grams of dried orange peel, 8 grams of Chinese herbaceous peony, 5 grams of moutan bark, 8 grams of cape jasmine (stir-fry), 5 grams of rhizoma alismatis, the rhizoma bolbostemmae 10
Gram, 6 times of water of dosing material total amount decoct 2 it is small when after filter, take the dregs of a decoction after filtering add again 8 times of water decoct 2 it is small when, filtering, is abandoned
The dregs of a decoction are removed, merge filtrate twice;
(2) relative density is 1.10-1.30 when the filtrate after merging being concentrated into 60-70 DEG C, is subsequently cooled to room temperature, adds second
Alcohol, it is stirring while adding to alcohol content in 50-60%, place 12 it is small when, filtering, takes filtrate recycling ethanol to be concentrated to give to no alcohol taste
To 70-80 DEG C relative density be 1.25-1.30 thick paste;
(3) mannitol, microcrystalline cellulose and thick paste (thick paste are taken:Mannitol:Microcrystalline cellulose=1:0.3:0.15), it is uniformly mixed
After pelletize, whole grain after 50-60 DEG C of dry particle to obtain the final product.
Embodiment 3
(1) take including 8 grams of green peel, 8 grams of dried orange peel, 9 grams of Chinese herbaceous peony, 9 grams of moutan bark, 5 grams of cape jasmine (stir-fry), 9 grams of rhizoma alismatis, the rhizoma bolbostemmae 7
Gram, 6 times of water of dosing material total amount decoct 2 it is small when after filter, take the dregs of a decoction after filtering add again 8 times of water decoct 2 it is small when, filtering, is abandoned
The dregs of a decoction are removed, merge filtrate twice;
(2) relative density is 1.10-1.30 when the filtrate after merging being concentrated into 60-70 DEG C, is subsequently cooled to room temperature, adds second
Alcohol, it is stirring while adding to alcohol content in 50-60%, place 12 it is small when, filtering, takes filtrate recycling ethanol to be concentrated to give to no alcohol taste
To 70-80 DEG C relative density be 1.25-1.30 thick paste;
(3) mannitol, microcrystalline cellulose and thick paste (thick paste are taken:Mannitol:Microcrystalline cellulose=1:0.3:0.15), it is uniformly mixed
After pelletize, whole grain after 50-60 DEG C of dry particle to obtain the final product.
The stagnation of QI due to depression of the liver particle of the present invention, uses common Chinese medicine material as raw material, scientific formulation, using the formulation of granule,
Dispersion degree is big, absorbs soon, and medicine arrival disease institute is rapid, significantly improves curative effect, treats both principal and secondary aspect of disease, clinical practice is safe.
The embodiments of the present invention are for illustration only, do not represent the quality of embodiment.
System embodiment described above is only schematical, wherein the unit illustrated as separating component can
To be or may not be physically separate, physics list is may or may not be as the component that unit is shown
Member, you can with positioned at a place, or can also be distributed in multiple network unit.It can be selected according to the actual needs
In some or all of module realize the purpose of this embodiment scheme.Those of ordinary skill in the art are not paying creativeness
Work in the case of, you can to understand and implement.
The foregoing is merely presently preferred embodiments of the present invention, is not intended to limit the invention, it is all the present invention spirit and
Within principle, any modification, equivalent replacement, improvement and so on, should all be included in the protection scope of the present invention.
Claims (10)
1. stagnation of QI due to depression of the liver particle, it is characterised in that including green peel, dried orange peel, Chinese herbaceous peony, moutan bark, cape jasmine (stir-fry), rhizoma alismatis, the rhizoma bolbostemmae.
2. stagnation of QI due to depression of the liver particle as claimed in claim 1, it is characterised in that including 5-10 grams of green peel, 5-10 grams of dried orange peel, Chinese herbaceous peony
5-10 grams, 5-10 grams of moutan bark, 5-10 grams of cape jasmine (stir-fry), 5-10 grams of rhizoma alismatis, 5-10 grams of the rhizoma bolbostemmae.
3. stagnation of QI due to depression of the liver particle as claimed in claim 2, it is characterised in that male including 6 grams of green peel, 6 grams of dried orange peel, 6 grams of Chinese herbaceous peony
5 grams of the root bark of tree peony, 5 grams of cape jasmine (stir-fry), 5 grams of rhizoma alismatis, 6 grams of the rhizoma bolbostemmae.
4. the preparation method of stagnation of QI due to depression of the liver particle, it is characterised in that comprise the following steps:
1) green peel, dried orange peel, Chinese herbaceous peony, moutan bark, cape jasmine (stir-fry), rhizoma alismatis, the rhizoma bolbostemmae, when 6 times of water decoction 2 of dosing material total amount is small are taken
After filter, take the dregs of a decoction after filtering add again 8 times of water decoct 2 it is small when, filtering, discards the dregs of a decoction, merges filtrate twice;
2) filtrate after merging is concentrated, is subsequently cooled to room temperature, add ethanol, it is stirring while adding, when placement 12 is small, mistake
Filter, takes filtrate recycling ethanol to be concentrated to give thick paste to no alcohol taste;
3) auxiliary material and the thick paste are taken, is pelletized after mixing, by whole grain after particle drying to obtain the final product.
5. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 4, it is characterised in that will merge in the step (2)
Relative density is 1.10-1.30 when the filtrate afterwards is concentrated into 60-70 DEG C.
6. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 5, it is characterised in that be concentrated to give in the step (2)
In 70-80 DEG C of relative density it is 1.25-1.30 to thick paste.
7. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 6, it is characterised in that auxiliary described in the step (3)
Material includes mannitol and microcrystalline cellulose.
8. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 7, it is characterised in that with quality in the step (3)
Than counting thick paste:Mannitol:Microcrystalline cellulose=1:0.3:0.15.
9. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 8, it is characterised in that dry temperature in the step (3)
Spend for 50-60 DEG C.
10. the preparation method of stagnation of QI due to depression of the liver particle as claimed in claim 9, it is characterised in that second is added in the step (2)
Alcohol is to alcohol content in 50-60%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711341561.8A CN107929451A (en) | 2017-12-14 | 2017-12-14 | One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711341561.8A CN107929451A (en) | 2017-12-14 | 2017-12-14 | One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107929451A true CN107929451A (en) | 2018-04-20 |
Family
ID=61944274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711341561.8A Pending CN107929451A (en) | 2017-12-14 | 2017-12-14 | One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107929451A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108888686A (en) * | 2018-07-06 | 2018-11-27 | 海王(湖北)中医药研究总院有限公司 | It is a kind of to treat stomachache, hypochondriac pain, gastroenteritic ulcer, the Chinese medical extract of depression and its preparation method and application |
CN110559373A (en) * | 2019-09-12 | 2019-12-13 | 河北万岁药业有限公司 | Preparation method of classic famous prescription liver-clearing decoction granules |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107349263A (en) * | 2017-07-24 | 2017-11-17 | 吉林大学 | A kind of a kind of reed mentioned in ancient books grass particle and preparation method thereof |
-
2017
- 2017-12-14 CN CN201711341561.8A patent/CN107929451A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107349263A (en) * | 2017-07-24 | 2017-11-17 | 吉林大学 | A kind of a kind of reed mentioned in ancient books grass particle and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
孙世发: "《老年病方药精华》", 30 September 1999, 人民卫生出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108888686A (en) * | 2018-07-06 | 2018-11-27 | 海王(湖北)中医药研究总院有限公司 | It is a kind of to treat stomachache, hypochondriac pain, gastroenteritic ulcer, the Chinese medical extract of depression and its preparation method and application |
CN110559373A (en) * | 2019-09-12 | 2019-12-13 | 河北万岁药业有限公司 | Preparation method of classic famous prescription liver-clearing decoction granules |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101172151A (en) | Traditional Chinese medicine for treating pancreatitis and preparation method thereof | |
CN104147534A (en) | Traditional Chinese medicine composition for treating various cancers | |
CN101125178A (en) | Traditional Chinese medicine for treating tumor | |
CN107929451A (en) | One kind treats stagnation of QI due to depression of the liver particle and preparation method thereof | |
CN102688317B (en) | Traditional Chinese medicine for treating liver cancer | |
CN102512617A (en) | Chinese herbal preparation for treating psoriasis | |
CN105943512B (en) | A kind of Exocarpium Citri Rubrum lozenge and preparation method thereof | |
CN109248305A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis | |
CN103830591A (en) | Traditional Chinese medicine formula for treating stroke and post-traumatic brain syndrome and preparation method of traditional Chinese medicine | |
CN102397528A (en) | Compound propolis composition for treating chicken infectious anemia and preparation method thereof | |
CN105194578A (en) | Traditional Chinese medicine for treating pediatric viral myocarditis | |
CN103705733A (en) | Chinese medicine capsule for treating arrhythmia and preparation method thereof | |
CN103611120A (en) | Preparation method of beef cattle cultivation composition for preventing and treating cow fetal movement | |
CN103611124A (en) | Beef cattle cultivation composition for preventing and treating cow fetal movement | |
CN108379444A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating insomnia | |
CN103007221A (en) | Traditional Chinese medicine for treating diarrhea and preparation method thereof | |
CN102805850B (en) | Preparation method of traditional Chinese medicine for treating fatigue type acute glomerulonephritis | |
CN102397533A (en) | Compound propolis composition for treating livestock egg drop syndrome and preparation method thereof | |
CN101041028B (en) | Traditional Chinese medicine preparation for liver diseases and its preparing method | |
CN106266962A (en) | A kind of medicament composing prescription for the nursing of puerpera's postpartum depression and preparation method | |
CN106038994A (en) | Food medicine for assisting in blood glucose reducing and preparation method thereof | |
CN104623428A (en) | Traditional Chinese medicine preparation for easing hereditary tyrosinemia and preparation method thereof | |
CN104758843A (en) | Traditional Chinese medicine preparation for treating hyperlipidemia and preparation method thereof | |
CN104645243A (en) | Traditional Chinese medicine composition for treating meningioma and preparation method thereof | |
CN103550583A (en) | Traditional Chinese medicine for treating skin itch with syndrome of pathogenic fire derived from stagnation of liver-qi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180420 |